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Background: The aim of this study was to evaluate the antimicrobial activity and the cytotoxicity of the ethanol
crude extract, fractions and isolated compounds from the twigs of Eriosema robustum, a plant used for the
treatment of coughs and skin diseases.
Methods: Column chromatographic and spectroscopic techniques were used to isolate and identify eight
compounds, robusflavones A (1) and B (2), orostachyscerebroside A (3), stigmasterol (4), 1-O-heptatriacontanoyl
glycerol (5), eicosanoic acid (6), 3-O-β-D-glucopyranoside of sitosterol (7) and 6-prenylpinocembrin (8), from
E. robustum. A two-fold serial microdilution method was used to determine the minimum inhibitory concentration
(MIC) against fungi and bacteria, and the 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide reduction
assay was used to evaluate the cytotoxicity.
Results: Fraction B had significant antimicrobial activity against Aspergillus fumigatus and Cryptoccocus neoformans
(MIC 0.08 mg/ml), whilst the crude extract and fraction A had moderate activity against A. fumigatus and
Candida albicans (MIC 0.16 mg/ml). Fraction A however had excellent activity against Staphylococcus aureus (MIC
0.02 mg/ml), Enterococcus faecalis and Escherichia coli (MIC 0.04 mg/ml). The crude extract had significant activity
against S. aureus, E. faecalis and E. coli. Fraction B had good activity against E. faecalis and E. coli (MIC 0.08 mg/ml).
All the isolated compounds had a relatively weak antimicrobial activity. An MIC of 65 μg/ml was obtained with
robusflavones A (1) and B (2) against C. albicans and A. fumigatus, orostachyscerebroside A (3) against A. fumigatus,
and robusflavone B (2) against C. neoformans. Compound 8 had the best activity against bacteria (average MIC
55 μg/ml). The 3 fractions and isolated compounds had LC50 values between 13.20 to > 100 μg/ml against Vero
cells yielding selectivity indices between 0.01 and 1.58.
Conclusion: The isolated compounds generally had a much lower activity than expected based on the activity of
the fractions from which they were isolated. This may be the result of synergism between different compounds in
the complex extracts or fractions. The results support the traditional use of E. robustum to treat infections. The
crude extract had a good activity and low preparation cost, and may be useful in topical applications to combat
microbial infections.
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The need for new, effective and affordable drugs to treat
microbial diseases in the developing world is one of the
issues facing global health today. Available drugs for the
treatment of these diseases are limited by factors ranging
from microbe resistance to safety, compliance and cost.
The use of medicinal plants for curative purposes is as
old as mankind and can be traced from the beginning of
civilisation. The interaction between man and his envi-
ronment is such that his food, shelter, the diseases that
afflict him and the cure of such diseases are all within
the environment. Thus, man uses his environment and
the resources of nature to combat diseases that afflict
him. Consequently over many centuries, people of vari-
ous countries of the world have embarked on what is
now known as traditional medicine [1]. It is estimated
that plants are still a major source of primary healthcare
for more than 60% of the world’s population.
Eriosema robustum, a member of Fabaceae family, is a
perennial non-climbing shrub with yellow flowers native
to Burundi, Ethiopia, Kenya, Rwanda, Tanzania, Uganda,
Democratic Republic of Congo and Cameroon [2]. It is
used traditionally for the treatment of coughs in East
Africa [3] and skin diseases in the Western Region of
Cameroon. Previous phytochemical study on this species
led to the isolation and characterization of two fla-
vonoids, robusflavones A and B, and five known com-
pounds [4]. As part of our ongoing study for bioactive
secondary metabolites from species of the Fabaceae fa-
mily [4-6], we have re-investigated the ethanol extract of
the twigs of E. robustum using bioassay-guided fraction-
ation. To investigate the potential use of an extract, frac-
tions or compounds, the cellular toxicity also has to be
determined. The therapeutic index, that is, ratio of activ-
ity against microorganisms to toxicity to animal cells, is
important.
We report herein the antimicrobial activity and cyto-
toxicity of the crude extract, fractions and the isolated
compounds (1–8). This is also the first report on the
isolation of a cerebroside, orostachyscerebroside A (3),
from the genus Eriosema.
Methods
Plant material
The twigs of E. robustum were collected in Dschang,
Western Region of Cameroon, in December 2011 and
identified at the Cameroon National Herbarium in
Yaoundé where a specimen was deposited under a voucher
number 35291/HNC.
Extraction and isolation
The dried and powdered twigs of E. robustum (2 kg)
were extracted for three days in ethanol (10 litres × 3
times) to yield the crude extract (115 g) after filtrationand solvent evaporation using a rotary evaporator. Part
of this extract (5 g) was subjected to a silica gel column
chromatography eluted with n-hexane (Hex), chloroform
(CHCl3), ethyl acetate (EtOAc) and methanol (MeOH)
in increasing polarity to give 40 fractions of 500 ml each
that were combined after monitoring with comparative
thin layer chromatography (Co-TLC) into 3 fractions: A
[(0.9 g, Hex - CHCl3 (100:0, 4:1, 3:2, 1:4) and CHCl3 -
EtOAc (100:0, 4:1)], B [(0.7 g, CHCl3 - EtOAc (4:1, 3:2, 1:4)
and C [(2.5 g, CHCl3 – EtOAc (1:4) and EtOAc - MeOH
(100:0, 3:7, 0:100)]. Fraction C did not have as many active
antimicrobial constituents separated by TLC in bioautogra-
phy as fractions A and B, and was not further investigated.
Fraction B was subjected to purification applying silica
gel column chromatography eluted with n-hexane, ace-
tone and methanol in order of increasing polarity to
yield 50 fractions of 150 ml each which were combined
in subfractions after monitoring with Co-TLC. Subfrac-
tions F25-26 and F27-30 eluted with n-hexane: acetone
(17:3) gave compounds 2 (9 mg), 4 (8 mg) and 6 (12 mg).
Subfractions F20-26 eluted with n-hexane: acetone (7:3, 3:2)
and F27-35 eluted with n-hexane: acetone (11:9, 1:9) were
similarly subjected to further silica gel column chroma-
tography eluted with n-hexane, ethyl acetate, metha-
nol in gradient polarity followed by preparative TLC
and Sephadex LH-20 to yield 1 (4 mg), 3 (10 mg), 5 (7 mg)
and 7 (9 mg).
Fraction A was subjected to Sephadex LH-20 to re-
move chlorophyll and the eluate was concentrated and
fractionated using similar silica gel column techniques
as described above for fraction B to give mainly 4 (3 mg)
and 8 (17 mg).
Orostachyscerebroside A (3): colourless amorphous; 1H
NMR (DMSO-d6, 400 MHz): δ 4.38 (br.t, 4.0 Hz, H-1b),
4.58 (br.t, 4.0 Hz, H-1a), 4.08 (m, H-2), 3.76 (m, H-3),
3.70 (m, H-4), 1.86-2.02 (2H, m, H-5), 5.63 (8H, m, H-6/
H-7/H-10/H-11/H-6′/H-7′/H-9′/H-10′), 1.23-1.33 (8H,
m, H-8/H-12/H-5′/H-11′), 1.40-1.65 (2H, m, H-9), 1.24-
1.31 (20H, m, H-13 to H-22), 1.50 (4H, m, H-23/H-19′),
0.84 (6H, t, 4.0 Hz, H-24/H-20′), 3.80 (m, H-2′), 1.26
(m, H-3′a), 2.02 (m, H-3′b), 1.02 (2H, m, H-4′), 1.02-
1.20 (2H, m, H-8′), 1.20-1.33 (14H, m, H-12′ to H-18′),
4.12 (d, 8.0 Hz, Glc-1″), 3.32 (m, H-2″), 4.96 (m, H-3″),
3.60 (m, H-4″), 3.03 (m, H-5″), 3.38 (m, H-6″a), 3.65
(m, H-6″b), 7.55 (d, 8.0 Hz, NH);
13C NMR (DMSO-d6,
100 MHz) δ: 69.4 (C-1), 50.3 (C-2), 70.9 (C-3), 71.3 (C-4),
34.8 (C-5), 129.8 (C-6), 130.1 (C-7), 27.4 (C-8/C-11′), 32.2
(C-9), 130.3 (C-10), 130.7 (C-11), 31.8 (C-12), 29.0-30.9
(C-13 to C-22), 22.6 (C-23/C-19′), 14.4 (Me-24/Me-20′),
174.2 (C-1′), 71.3 (C-2′), 34.8 (C-3′), 24.4 (C-4′/C-8′),
27.1 (C-5′), 130.1 (C-6′/C-10′), 129.8 (C-7′/C-9′),
29.0-30.9 (C-12′ to C-18′), 103.9 (C-1″), 73.9 (C-2″),
76.9 (C-3″), 70.4 (C-4″), 77.3 (C-5″), 61.4 (C-6″);
MALDI-FT-MS m/z: 866.6720 ([M +H]+, C50H92O10N),
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IR spectra were recorded on a Bruker Alpha FT-IR spec-
trometer (Optik GmbH, Germany). UV spectra were re-
corded on Thermo Electron Helios spectrophotometer
(UVB 120726, England).
1H- and 13C-NMR spectra were recorded with a
Bruker spectrometer at 500 MHz and a Varian spectro-
meter at 400 MHz. Chemical shifts (δ) were quoted in
parts per million (ppm) from the internal standard tetra-
methylsilane (TMS). Deuterated solvents as dimethyl
sulfoxide (DMSO-d6, for compounds 1, 2, 3, 7 and 8),
and chloroform (CDCl3, for compounds 4, 5 and 6) were
used for the NMR experiments. Mass spectrometry was
performed on a Thermo Scientific LTQ-Orbitrap instru-
ment coupled to a MALDI (matrix-assisted laser desorp-
tion ionization) or liquid chromatography electrospray
ionization source. Column chromatography was per-
formed on MN silica gel 60 (0.063-0.2 mm/70–230)
mesh. Preparative TLC was performed using high-purity
grade silica gel powder (60 A, 2–25 μm) Sigma-Aldrich,
Germany. Pre-coated plates of TLC silica gel 60 F254
(Merck, Germany) were used for monitoring fractions
and spots were detected with UV light (254 and
365 nm) and then sprayed with 30% H2SO4 followed
by heating up to 110°C.
Antimicrobial assay
The two-fold serial microdilution method described by
Eloff (1998) was used to determine the minimum inhibi-
tory concentration (MIC) values for the extract, fractions
and isolated compounds against bacteria [7] and a modi-
fication of [7] by Masoko et al. (2005) was used for fungi
[8]. The respective MIC of the samples was determined
using two Gram-positive bacteria, Staphylococcus aureus
(ATCC 29213) and Enterococcus faecalis (ATCC 29212),
two Gram-negative bacteria, Pseudomonas aeruginosa
(ATCC 27853) and Escherichia coli (ATCC 25922); and
three clinical isolates of the pathogenic fungi Candida
albicans, Cryptococcus neoformans and, Aspergillus niger
along with Candida albicans (ATCC 10231). Some fun-
gal strains used were cultured from clinical cases of fun-
gal infectious diseases in animals (before treatment) in
the Department of Veterinary Tropical Diseases, Faculty
of Veterinary Science. C. albicans was isolated from a
Gouldian finch, C. neoformans from a cheetah, while A.
fumigatus was isolated from a chicken which suffered
from a systemic mycosis.
In the antibacterial tests, 100 μl of the (10 mg/ml)
crude extract and fractions or (1 mg/ml) compounds induplicate dissolved in dimethyl sulfoxide (DMSO) were
serially diluted two-fold with sterile distilled water in 96-
well microtitre plates and 100 μl bacterial culture in
Mueller Hinton broth (MHB) (Fluka, Germany) was ad-
ded to each well. DMSO was used to dissolve the com-
pounds because acetone used in the original method [7]
did not dissolve all the compounds well. The densities of
bacterial cultures were approximately 2.6 × 1012 cfu/ml,
S. aureus; 1.5 × 1010 cfu/ml, E. faecalis; 5.2 × 1013 cfu/ml,
P. aeruginosa and 3.0 × 1011 cfu/ml, E. coli, obtained by
adding 99 ml of MHB to 1 ml of each microorganism
from the freshly prepared overnight bacterial culture in
Mueller Hinton broth [9]. Gentamicin and DMSO were
used as positive and negative controls, respectively. The
microtitre plates were sealed in plastic bags to avoid
contamination in the laboratory and were incubated
overnight at 37°C. Afterwards, 40 μl of 0.2 mg/ml of p-
iodonitrotetrazolium violet (INT) (Sigma, Germany) was
added to each well to indicate microbial growth. The mi-
crotitre plates were further incubated at 37°C for 2 h
and the minimal inhibitory concentration (MIC) was de-
termined as the lowest concentration inhibiting micro-
bial growth, indicated by a decrease in the intensity of
the red colour of the formazan [10].
For the antifungal assay, 100 μl of the crude extract,
fractions and compounds dissolved in DMSO at the
same concentrations, as described above for the bacteria,
were two-fold serially diluted with distilled water in 96-
well microtitre plates, and 100 μl of fungal culture in
Potato Dextrose broth (Sigma, Germany) was added to
each well [8]. Amphotericin B and DMSO were used as
positive and negative controls, respectively. INT (40 μl)
at 0.2 mg/ml in distilled water was added to each well as
a growth indicator and the covered microplates were in-
cubated at 35°C after sealing in a plastic bag. The MIC
value was recorded after 16 and 24 h incubation for C.
albicans and A. fumigatus, and after 24 and 36 h incuba-
tion for C. neoformans as the lowest concentration of
the sample that inhibited fungal growth. The colourless
salt of tetrazolium acts as an electron acceptor and is re-
duced to a red coloured formazan product by biologic-
ally active organisms [11,12]. The solution in the well
remains clear or shows a marked decrease in intensity of
colour after incubation with INT at the concentration
where fungal growth is inhibited. The experiment was




zolium bromide) reduction assay is one of the most fre-
quently used methods for measuring cell proliferation
and cytotoxicity. The intensity of colour (measured spec-
trophotometrically) of the MTT formazan produced by
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number of live cells present. MTT is a yellow water-
soluble tetrazolium dye that is reduced by live, but not
dead, cells to a purple formazan product that is insoluble
in aqueous solutions. The viable cell growth after incu-
bation with extract, fractions and isolated compounds
was determined using the tetrazolium-based colorime-
tric MTT assay described by Mosmann (1983) [13]. In
short, monkey Vero cells of a subconfluent culture were
harvested and centrifuged at 200 × g for 5 min, and re-
suspended in growth medium to 5 × 104 cells/ml. The
growth medium used was Minimal Essential Medium
(MEM, Sigma) supplemented with 0.1% gentamicin
(Virbac) and 5% foetal calf serum (Sigma). A total of
200 μl of the cell suspension is pipetted into each well of
columns 2 to 11 of a sterile 96-well microtitre plate. A
200 μl aliquot of growth medium was added to wells of
columns 1 and 12 to minimize the “edge effect” and
maintain humidity. The plates were incubated for 24 h
at 37°C in a 5% CO2 incubator, until the cells were in
the exponential phase of growth. The MEM was aspi-
rated from the cells, and replaced with 200 μl of extract,
fractions and compounds at differing concentrations
(serial dilution prepared in growth medium). The cells
were disturbed as little as possible during the aspiration
of medium and addition of test samples. Each dilution
was tested in quadruplicate. The microtitre plates were
incubated at 37°C in a 5% CO2 incubator for 48 h with
test compounds, fractions or extract. Untreated cells and
positive control (doxorubicin, Pfizer Laboratories) were
included. After incubation, cells were washed with
150 μl phosphate buffered saline (PBS) and fresh MEM
(200 μl) was added to each well together with 30 μl
MTT (Sigma, stock solution of 5 mg/ml in PBS). The
plates were then incubated for a further 4 h at 37°C.
After incubation with MTT the medium in each well
was carefully removed, without disturbing the MTT
crystals in the wells. The MTT formazan crystals were
dissolved by adding 50 μl DMSO to each well and the
plates gently shaken until the MTT solution was dis-
solved. The amount of MTT reduction was measured
immediately by detecting absorbance in a microplate
reader (Versamax, Molecular Devices) at a wavelength
of 570 nm and a reference wavelength of 630 nm. The
wells in column 1, containing medium and MTT but no
cells, were used to blank the plate reader. The LC50
values were calculated as the concentration of test sam-
ple resulting in a 50% reduction of absorbance compared
to untreated cells.
Results and discussion
Chemical composition and antimicrobial activity
The EtOH crude extract from the twigs of Eriosema
robustum was subjected to repeated silica gel columnchromatography followed by preparative TLC and Sepha-
dex LH-20 to afford eight compounds including robusfla-
vones A (1, yellow amorphous, m/z 362, C17H14O9) and B
(2, yellow amorphous, m/z 332, C16H12O8) [4], orosta-
chyscerebroside A (3) [14], stigmasterol (4, white powder,
m/z 412, C29H48O) [15], 1-O-heptatriacontanoyl glycerol
(5, white powder, m/z 484, C30H60O4) [16], eicosanoic acid
(6, white powder, m/z 312, C20H40O2) [17], 3-O-β-D-
glucopyranoside of sitosterol (7, white crystals, m/z
C35H60O6) [18] and 6-prenylpinocembrin (8, yellow,
m/z C20H20O4) [19] (Figure 1). The structures elucidation
of the compounds were achieved by interpretation of their
NMR, IR, UV and MS data, and by comparison with those
reported in the literature. To the best of our knowledge
this is the first report on the isolation of a cerebroside,
orostachyscerebroside A (3), from the genus Eriosema.
Orostachyscerebroside A (3) was found for the first time
in the aerial parts of Orostachys japonicas in 2012 [14].
The antimicrobial activity and cytotoxicity of the crude
extract, fractions from the column chromatography of
the extract and isolated compounds (1–8) were deter-
mined and the results are presented in Tables 1, 2 and 3.
Many authors consider the antimicrobial activity of ex-
tracts to be significant if the MIC value is 0.1 mg/ml or
lower, moderate if 0.1 <MIC ≤ 0.625 mg/ml and weak if
MIC > 0.625 mg/ml [20,21]. When reporting the anti-
microbial activity of the isolated compounds, it is signifi-
cant if the MIC is 10 μg/ml or lower, moderate if 10 <
MIC ≤ 100 μg/ml and low if MIC > 100 μg/ml [21,22].
Based on these criteria, all the tested samples had sig-
nificant to weak antifungal activities against the four
fungi with MIC values between 80 and 1250 μg/ml
(Table 1). Fraction B was significantly active against As-
pergillus fumigatus and Cryptoccocus neoformans with
an MIC of 0.08 mg/ml, while the crude extract and frac-
tion A had moderate activity against Aspergillus fumiga-
tus and Candida albicans (ATCC) with an MIC value of
0.16 mg/ml in all cases. Fraction B had the highest anti-
fungal activity among the tested fractions and extract
with an average MIC of 0.61 mg/ml followed by fraction
A (average MIC of 0.65 mg/ml) and the crude extract
(average MIC of 0.88 mg/ml).
The most active isolated compounds had moderate an-
tifungal activity with the MIC value of 65 μg/ml. These
included robusflavones A (1) and B (2) against C. albi-
cans (ATCC) and A. fumigatus, compounds 4 and 7
against C. albicans (ATCC), as well as compound 6
against A. fumigatus and C.neoformans, orostachyscere-
broside A (3) against A. fumigatus, and robusflavone B
(2) against C. neoformans. Compounds 5 and 7 had
weak antifungal activity against C. neoformans (MIC >
250 μg/ml in both cases). The animal pathogenic isolate
C. albicans was more resistant to the tested samples




































Figure 1 Chemical structures of compounds (1–8) isolated from E. robustum.
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for compounds, respectively. Nevertheless, robusflavone
B (2) had the best antifungal activity (average MIC of
88 μg/ml), followed by compounds 3 and 6 (average MIC
of 110 μg/ml), compound 7 (average MIC of 157 μg/ml)
and robusflavone A (1) (average MIC of 165 μg/ml).
The antibacterial activity of the crude extract, fractions
and isolated compounds were determined against four
bacteria with MIC values ranging from 0.02 to 0.31 mg/ml
and from 31.3 to 250 μg/ml, respectively (Table 1). The
crude extract had good activity against S. aureus, E. fae-
calis and E. coli (MIC value of 0.08 mg/ml) and had
moderate activity against P. aeruginosa (MIC value of
0.31 mg/ml). Fraction A had excellent activity against S.
aureus (MIC of 0.02 mg/ml), E. faecalis and E. coli (MIC
of 0.04 mg/ml) and reasonable activity against P. aeru-
ginosa (MIC value of 0.31 mg/ml). The Gram-negative
P. aeruginosa and the Gram-positive S. aureus were
more resistant to fraction B with MIC values of 0.31and 0.16 mg/ml, respectively. However, fraction B had
significant activity against E. faecalis and E. coli with
an MIC value of 0.08 mg/ml. Compound 8 had moderate
activity against S. aureus (MIC value of 31.3 μg/ml) and
had reasonable activity against other bacteria with an MIC
value of 63 μg/ml. Other constituents had also reasonable
antibacterial activity against P. aeruginosa with the MIC
value of 63 μg/ml as well as robusflavone B (2) and com-
pound 6 against E. faecalis (MIC of 63 μg/ml). Amongst
all the isolated compounds, 6-prenylpinocembrin (8) had
the highest antibacterial activity with an average MIC of
55.1 μg/ml and average total activity of 20 ml/mg followed
by robusflavone B (2), and compounds 5 and 6 (average
MIC of 94 μg/ml and average total activity of 12 ml/mg),
as well as robusflavone A (1) with an average MIC of
203.3 μg/ml and average total activity of 7 ml/mg.
The crude extract and fractions were found to be more
active than the isolated compounds against the bacteria
and the fungi. The antibacterial activity of fraction A is
Table 1 Minimum inhibitory concentration (MIC) of the extract, fractions and compounds (1–8) from E. robustum
against fungi (C.a, C.A, A.f, C.n) and bacteria (S.a, P.a, E.f, E.c)
Samples Fungi (MIC values) Bacteria (MIC values)
C.a C.A A.f C.na Average S.a P.a E.f E.c Average
16 h 24 h 16 h 24 h 16 h 24 h 24 h 36 h
Extract and Fractions (mg/ml)
Crude extract 1.25 1.25 1.25 1.25 0.16 0.63 0.63 0.63 0.88 0.08 0.31 0.08 0.08 0.14
Fraction A 0.63 0.63 0.16 0.32 0.32 0.63 1.25 1.25 0.65 0.02 0.31 0.04 0.04 0.10
Fraction B 1.25 1.25 0.32 0.63 0.08 0.63 0.08 0.63 0.61 0.16 0.31 0.08 0.08 0.16
Compounds (μg/ml)
Robusflavone A (1) 250 250 65 65 65 125 250 250 165 250 63 250 250 203.3
Robusflavone B (2) 125 125 65 65 65 125 65 65 88 125 63 63 125 94
Orostachyscerebroside A (3) 250 250 130 250 130 250 250 250 220 125 63 125 125 109.5
Stigmasterol (4) 125 125 125 125 65 65 125 125 110 125 63 250 250 172
1-O-Heptatriacontanoyl glycerol (5) 250 250 65 65 125 125 250 250 173 125 63 125 125 109.5
Eicosanoic acid (6) 250 250 125 125 125 125 > 250 > 250 188 63 63 125 125 94
3-O-β-D-Glucopyranoside of sitosterol (7) 125 125 125 125 65 125 65 125 110 125 63 63 125 94
6-Prenylpinocembrin (8) 125 125 65 65 125 250 > 250 > 250 157 31.3 63 63 63 55.1
Controls (μg/ml)
Amp B 30 30 10 30 65 125 > 250 > 250 99 - - - - -
Gen - - - - - - - - - < 3.91 < 3.91 < 3.91 < 3.91 < 3.91
DMSOb na na na na na na na na na na na na
C.a: Candida albicans (isolate), C.A: Candida albicans (ATCC), C.n: Cryptococcus neoformans, A.f: Aspergillus fumigatus, E.c: Escherichia coli, E.f: Enterococcus faecalis,
S.a: Staphylococcus aureus, P.a: Pseudomonas aeruginosa, Amp B: Amphotericin B, Gen: Gentamicin, aWith this microorganism little reaction was observed after
16 h and values were measured after 24 and 36 h, bThe final concentration of DMSO used was less than 10%, na: not active.
The results are the means of three replicates for fungi and two replicates for bacteria and the standard deviation was zero.
Table 2 Total activity in ml/g of crude extract and fractions (A and B) from E. robustum calculated by dividing mass
in g of extract or fractions with their MIC values [20]
Samples Fungi Bacteria
C.a C.A A.f C.n Average S.a P.a E.f E.c Average
16 h 24 h 16 h 24 h 16 h 24 h 24 h 36 h
Extract and Fractions
Crude extract 4000 4000 4000 4000 31250 7937 7937 7937 8883 62500 16129 62500 62500 50907
Fraction A 1429 1429 5625 2813 2813 1429 720 720 2123 45000 2903 22500 22500 23226
Fraction B 560 560 2188 1111 8750 1111 8750 1111 3018 4375 2258 8750 8750 6033
Compounds
Robusflavone A (1) 4 4 13.4 13.4 13.4 8 4 4 8 4 16 4 4 7
Robusflavone B (2) 8 8 13.4 13.4 13.4 8 13.4 13.4 11 8 16 16 8 12
Orostachyscerebroside A (3) 4 4 7.7 4 7.7 4 4 4 4.5 8 16 8 8 9.1
Stigmasterol (4) 8 8 8 8 13.4 13.4 8 8 9 8 16 4 4 8
1-O-Heptatriacontanoyl glycerol (5) 4 4 13.4 13.4 8 8 4 4 7 8 16 8 8 10
Eicosanoic acid (6) 4 4 8 8 8 8 < 8 < 8 7 16 16 8 8 12
3-O-β-D-Glucopyranoside of sitosterol (7) 8 8 8 8 13.4 8 13.4 8 9 8 16 16 8 12
6-Prenylpinocembrin (8) 8 8 13.4 13.4 8 4 < 4 < 4 8 32 16 16 16 20
C.a: Candida albicans (isolate), C.A: Candida albicans (ATCC), C.n: Cryptococcus neoformans, A.f: Aspergillus fumigatus, E.c: Escherichia coli, E.f: Enterococcus faecalis,
S.a: Staphylococcus aureus, P.a: Pseudomonas aeruginosa.
The inverse of MIC in ml/mg was calculated for compounds (1–8).
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Table 3 Cytotoxicity of the crude extract, fractions and compounds from E. robustum and their selectivity index (SI)
Samples Cytotoxicty (LC50, μg/ml) Selectivity index
a
C.a C.A A.f C.n S.a P.a E.f E.c
Extract and fractions
Crude extract 53.45 ± 2.21 0.04 0.04 0.21* 0.08 0.67 0.17 0.67 0.67
Fraction A 17.91 ± 1.71 0.03 0.09* 0.05* 0.01 0.90 0.06 0.45 0.45
Fraction B 93.76 ± 25.62 0.08 0.22* 0.66* 0.66* 0.59 0.30 1.17 1.17
Compounds
Robusflavone A (1) 13.20 ± 0.02 0.05 0.20 0.16* 0.05 0.05 0.21 0.05 0.05
Robusflavone B (2) 30.42 ± 3.26 0.24 0.47 0.36* 0.47 0.24 0.48 0.48 0.24
Orostachyscerebroside A (3) > 100 0.4 0.53* 0.53* 0.4 0.8 1.59 0.8 0.8
Stigmasterol (4) 54.97 ± 11.05 0.44 0.44 0.85 0.44 0.44 0.87 0.22 0.22
1-O-Heptatriacontanoylglycerol (5) 91.52 ± 28.38 0.37 1.41 0.73 0.37 0.73 1.45 0.73 0.73
Eicosanoic acid (6) NT - - - - - - - -
3-O-β-D-Glucopyranoside of sitosterol (7) >100 0.80 0.80 1.17* 1.17* 0.80 1.58 1.58 0.80
6-Prenylpinocembrin (8) 21.87 ± 0.37 0.17 0.34 0.13* 0.09 0.70 0.35 0.35 0.35
Control
Dox 3.32 ± 1.31
C.a: Candida albicans (isolate), C.A: Candida albicans (ATCC), A.f: Apergillus fumigatus, C.n: Cryptoccocus neoformans, E.c: Escherichia coli, E.f: Enterococcus faecalis,
S.a: Staphylococcus aureus, P.a: s Dox: Doxorubicin with LC50 in μM, NT: not tested,
aSI = LC50 /MIC, *SI obtained from average MIC.
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value of 100 μg/ml [20,23] and an average total activity
of 23 226 ml/g. Fraction B had good antifungal activity
against A. fumigatus and C. neoformans with an MIC
value of 80 μg/ml and total activity of 8 750 ml/g after
16 and 24 h of incubation. This implies that if 1 g of
fraction B from the ethanol extract was diluted to 8.75
litres it would still inhibit the growth of A. fumigatus
and C. neoformans. Compound 8, obtained from the
most antibacterial-active part, fraction A, had the high-
est antibacterial activity amongst all the isolated com-
pounds with an average MIC of 55.1 μg/ml and average
total activity of 20 ml/mg. The antibacterial activity
of compound 8 is in agreement with previous results
reported on the antimicrobial activity of similar com-
pounds bearing the prenyl group on their structures
[6,24]. Robusflavones A (1) and B (2) characterized earl-
ier as two new antioxidant flavones [4] had moderate ac-
tivities against fungi and bacteria with mean MIC values
of 165, 88, 203.3 and 94 μg/ml, and average total acti-
vities of 8, 11, 7 and 12 ml/mg, respectively. The cere-
broside and the glycerol derivative (compounds 3 and 5)
had similar antibacterial activity (both with average MIC
of 109.5 μg/ml) but had slightly different antifungal ac-
tivity with average MIC values of 220 and 173 μg/ml,
respectively.
From the results, it is evident that the isolated com-
pounds did not have good activity against the tested
microorganisms as observed for extract and fractions.
This supports the conclusion of Lewis and Ausubel
(2006) that plants contain many compounds with lowantimicrobial activity and use other mechanisms to
combat microbial growth [25]. In some of our previous
work, it has been found that crude extracts and fractions
have excellent potential activity in treating microbial in-
fections and may even have as good or higher activity
than commercially used antimicrobials in the field or
clinical trials [26,27]. This could be justified by the fact
that, constituents in plant extract or fractions interacting
in a synergistic manner may not be highly active when
they are not part of a mixture with synergistic com-
pounds. The antimicrobial activity of the crude extract,
fractions and compounds (1–3, 5, 6 and 8) are reported
here for the first time.
Cytotoxicity
The crude extract, fractions and isolated compounds
from the twigs of E. robostum were evaluated for their
cytotoxicity against monkey kidney Vero cells in vitro
using the MTT (3-(4,5-dimethylythiazol-2-yl)-2,5-diphe-
nyl-2H-tetrazolium hydrobromide) assay and the results
are presented in Table 3. Apart from eicosanoic acid (6)
that was not tested, compounds 3 and 7 had LC50 value
greater than 100 μg/ml whilst the crude extract, frac-
tions and others isolated compounds (1, 2, 4, 5 and 8)
had cytotoxic activity against the Vero cells with LC50
values ranging from 13.20 to 91.52 μg/ml. Our samples,
and especially the tested compounds, could be consid-
ered less toxic than the positive control doxorubicin
(LC50 = 3.32 μM) and by taking into consideration the
criterion of the American National Cancer Institute
(NCI) regarding the cytotoxicity of pure compounds
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30.42 and 21.87 μg/ml for compounds 1, 2 and 8 with
the same basic skeleton (flavonoid) were lower than
those of others compounds and more cell lines should
be tested in a comprehensive screen to confirm their
probable safety in terms of cytotoxicity. The selectivity
index (SI) values of the tested samples ranged from 0.01
to 1.58 and could be considered as poor when taking in
consideration that the ratio for a good therapeutic index
for a remedy or drug should be ≥ 10 [29]. This is the first
report on the cytotoxicity of the extract, fractions as well
as compounds 1, 2, 3, 5 and 8 from E. robustum against
Vero cells.
Fraction B had good antifungal activity with a total ac-
tivity of 3018 ml/g for the fraction. One should keep in
mind that the 5 g of extract separated by column chro-
matography was obtained from 87 g of the original dried
plant material. In comparing the activity of different
plants the concept of total activity was developed [30].
This indicates the volume to which level the extract
from 1 g of dried plant material can be diluted and still
inhibit the growth of the microorganism. The total acti-
vity of 3018 ml/g for fraction B was derived from 87 g of
the original dried plant material. The total activity per
gram dried plant material for fungi was therefore
c. 35 ml/g. The same argument shows that fraction A
had a total antibacterial activity of 267 ml/g dried plant
material. The crude extract and fractions had fungistatic
effect in most of the cases such as the crude extract
against A. fumigatus, fraction A against C. albicans and
A. fumigatus, and fraction B against C. albicans, A. fumi-
gatus and C. neoformans. It is noteworthy that the crude
extract had a fungicidal activity against the two Candida
and the Cryptococcus species, but the fractions had
mainly fungistatic activity. This again points to the pro-
bability of synergistic activities.
With the high total activity of the crude extract and
the ease of preparation, there is a reasonable possibility
that the crude extract can be used as topical treatment
for fungal and especially bacterial infections. Manipula-
tion of the extract by for example solvent-solvent frac-
tionation may lead to extracts with a higher activity and
possibly a lower cytotoxicity [31].Conclusion
The results obtained support the traditional use of E.
robustum to treat infections. The crude extract had
good activity with low toxicity to animal cells, and
may be useful in topical applications to combat mi-
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